| Product Name | MF | CAS | Details |
|---|
| N-Methyl-N-trimethylsilyltrifluoroacetamide, Trimethylsilylating Agent，≥ 90.0% | C6H12F3NOSi | 24589-78-4 | Details |
| Phenyl Acetate, ≥ 98.0% | C8H8O2 | 122-79-2 | Details |
| Methyl 4-Chloro-2-methylphenoxyacetate, ≥ 94.0% | C10H11ClO3 | 2436-73-9 | Details |
| N-Formylglycine, ≥ 98.0% | C3H5NO3 | 2491-15-8 | Details |
| N,N-Dimethyl-n-octylamine, ≥ 95.0% | C10H23N | 7378-99-6 | Details |
| L-O-Phosphoserine, ≥ 98.0% | C3H8NO6P | 407-41-0 | Details |
| Protoporphyrin IX；≥95% | C34H34N4O4 | 553-12-8 | Details |
| N-(4-Aminobenzoyl)-β-alanine, ≥ 98.0% | C10H12N2O3 | 7377-08-4 | Details |
| Loxoprofen Sodium Salt Dihydrate, ≥ 98% | C15H21NaO5 | 226721-96-6 | Details |
| n-Octanoic Anhydride, ≥ 95.0% | C16H30O3 | 623-66-5 | Details |
| Nitrocefin | C21H16N4O8S2 | 41906-86-9 | Details |
| Piperazine Adipate, ≥ 98.0% | C10H20N2O4 | 142-88-1 | Details |
| p-Hydrazinobenzenesulfonic Acid Hemihydrate, ≥ 98.0% | C6H8N2O3S | 98-71-5 | Details |
| Monomethyl Azelate, ≥ 97.0% | C10H18O4 | 2104-19-0 | Details |
| Norlaudanosine Hydrochloride, ≥ 98.0% | C20H25NO4.HCl | 6429-04-5 | Details |
| N,N-Diethylethylenediamine, ≥ 98.0% | C6H16N2 | 100-36-7 | Details |
| Ricinoleic Acid, ≥ 80.0% | C18H34O3 | 141-22-0 | Details |
| N-Acetyl-D-mannosamine Monohydrate, ≥ 98.0% | C8H15NO6 | 3615-17-6 | Details |
| N-Benzylacetamide, ≥ 98.0% | C9H11NO | 588-46-5 | Details |
| Monomethyl Suberate；≥ 98.0% | C9H16O4 | 3946-32-5 | Details |
| N-(2-Aminoethyl)piperazine, ≥ 99.0% | C6H15N3 | 140-31-8 | Details |
| S-Furfuryl Thioacetate, ≥ 97.0% | C7H8O2S | 13678-68-7 | Details |
| Prilocaine Hydrochloride, ≥ 98.0% | C13H21ClN2O | 1786-81-8 | Details |
| Stiripentol, ≥ 98.0% | C14H18O3 | 49763-96-4 | Details |
| tert-Butyl (4R,6S)-6-(Hydroxymethyl)-2,2-dimethyl-1,3-dioxane-4-acetate, ≥ 98.0% | C13H24O5 | 124655-09-0 | Details |
| Proparacaine Hydrochloride, ≥ 98.0% | C16H27ClN2O3 | 5875-06-9 | Details |
| Paromomycin Sulfate, ≥ 94.0% | C23H47N5O18S | 1263-89-4 | Details |
| N,N'-Diphenylbenzidine, ≥ 98.0% | C24H20N2 | 531-91-9 | Details |
| Methotrexate Hydrate, ≥ 98.0% | C20H24N8O6 | 133073-73-1 | Details |
| Paraldehyde；≥ 98.0% | C6H12O3 | 123-63-7 | Details |
| N,N-Diethyl-m-toluidine, ≥ 99.0% | C11H17N | 91-67-8 | Details |
| Methocarbamol, ≥ 98.0% | C11H15NO5 | 532-03-6 | Details |
| Phthalocyanine, ≥ 93.0% | C32H18N8 | 574-93-6 | Details |
| Sodium Abietate, ≥ 85.0% | C20H29NaO2 | 14351-66-7 | Details |
| Methyl Hyodeoxycholate, ≥ 98.0% | C25H42O4 | 2868-48-6 | Details |
| N-(2-Diethylaminoethyl)-1-naphthylamine Oxalate, ≥ 98.0% | C18H24N2O4 | 29473-53-8 | Details |
| Neostigmine Bromide, ≥ 99.0% | C12H19BrN2O2 | 114-80-7 | Details |
| N-Acetyl-3,5-dimethyl-1-adamantanamine, ≥ 97.0% | C14H23NO | 19982-07-1 | Details |
| Methyl 4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate, ≥ 98.0% | C16H16N4O3 | 155405-80-4 | Details |
| N-Butyl-N-(4-hydroxybutyl)nitrosamine, ≥ 90.0% | C8H18N2O2 | 3817-11-6 | Details |
| m-Tolyl Acetate, ≥ 99.0% | C9H10O2 | 122-46-3 | Details |
| Sodium (+/-)-10-Camphorsulfonate, ≥ 98.0% | C10H17NaO4S | 34850-66-3 | Details |
| N-(3-Aminopropyl)-N-methylaniline, ≥ 96.0% | C10H16N2 | 53485-07-7 | Details |
| N-Ethyl-o-crotonotoluidide, ≥ 95.0% | C13H17NO | 124236-29-9 | Details |
| Piperazine Citrate Hydrate, ≥ 98.0% | C24H46N6O14 | 144-29-6 | Details |
| N-Vinyl-epsilon-caprolactam；≥ 98.0% | C8H13NO | 2235-00-9 | Details |
| Styrene Oxide；≥ 98.0% | C8H8O | 96-09-3 | Details |
| S-(2-Benzothiazolyl) (Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)thioacetate, ≥ 97.0% | C13H10N4O2S3 | 80756-85-0 | Details |
| S-Benzoylthiamine O-Monophosphate, ≥ 98.0% | C19H23N4O6PS | 22457-89-2 | Details |
| Pentadecylcyclohexane, ≥ 98.0% | C21H42 | 6006-95-7 | Details |
| N,N-Dimethyldecylamine, ≥ 93.0% | C12H27N | 1120-24-7 | Details |
| Methyl Cholate, ≥ 97.0% | C25H42O5 | 1448-36-8 | Details |
| N，N-Dimethylethylamine；≥ 98.0% | C4H11N | 598-56-1 | Details |
| Phytosphingosine, ≥ 98.0% | C18H39NO3 | 554-62-1 | Details |
| n-Octyl 4-Hydroxybenzoate, ≥ 98.0% | C15H22O3 | 1219-38-1 | Details |
| Oxamic Acid, ≥ 97.0% | C2H3NO3 | 471-47-6 | Details |
| Lithium Acetoacetate, ≥ 95.0% | C4H7LiO3 | 3483-11-2 | Details |
| Manidipine Dihydrochloride, ≥ 98.0% | C35H40Cl2N4O6 | 89226-75-5 | Details |
| N-Methyl-2-phenylethylamine, ≥ 96.0% | C9H13N | 589-08-2 | Details |
| Monomethyl 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate, ≥ 98.0% | C16H16N2O6 | 74936-72-4 | Details |
| Sphingomyelin (Egg, Chicken) | C39H79N2O6P | 383907-87-7 | Details |
| N,N,N',N'-Tetrakis(2-hydroxypropyl)ethylenediamine, ≥ 98.0% | C14H32N2O4 | 102-60-3 | Details |
| Mepivacaine Hydrochloride, ≥ 98.0% | C15H22N2O.ClH | 1722-62-9 | Details |
| L-Ornithine L-Aspartate, ≥ 96.0% | C5H12N2O2.C4H7NO4 | 3230-94-2 | Details |
| N-(2-Cyanoethyl)-N-ethylaniline, ≥ 98.0% | C11H14N2 | 148-87-8 | Details |
| N-Ethylbutylamine, ≥ 99.0% | C6H15N | 13360-63-9 | Details |
| Methylene Blue hydrate | C16H20ClN3OS | 122965-43-9 | Details |
| Orphenadrine Hydrochloride, ≥ 98.0% | C18H24ClNO | 341-69-5 | Details |
| Sodium Meclofenamate Monohydrate, ≥ 98.0% | C14H10Cl2NO2.Na | 6385-02-0 | Details |
| Methyl Bromoacetate, ≥ 95.0% | C3H5BrO2 | 96-32-2 | Details |
| Methyl Methoxyacetate, ≥ 95.0% | C4H8O3 | 6290-49-9 | Details |
| Sodium 2-Mercaptoethanesulfonate, ≥ 95.0% | C2H7NaO3S2 | 19767-45-4 | Details |
| n-Octyltriethoxysilane, ≥ 97.0% | C14H32O3Si | 2943-75-1 | Details |
| N,N-Dimethyltetradecylamine, ≥ 90.0% | C16H35N | 112-75-4 | Details |
| Octaphenylcyclotetrasiloxane；≥ 98.0% | C48H40O4Si4 | 546-56-5 | Details |
| Monomethyl Fumarate；≥ 98.0% | C5H6O4 | 2756-87-8 | Details |
| N,N-Dimethyldodecylamine, ≥ 95.0% | C14H31N | 112-18-5 | Details |
| Phenylhydroquinone, ≥ 98.0% | C12H10O2 | 1079-21-6 | Details |
| Neostigmine Methyl Sulfate, ≥ 98.0% | C12H19N2O2.CH3O4S | 51-60-5 | Details |
| Octenidine Dihydrochloride, ≥ 98.0% | C36H64Cl2N4 | 70775-75-6 | Details |
| Monomethyl Maleate, ≥ 90.0% | C5H6O4 | 3052-50-4 | Details |
| N-Ethyltoluenesulfonamide (o- and p- mixture), ≥ 98.0% | C17H24N2O4S2 | 76902-32-4 | Details |
| Pyrimethamine, ≥ 98.0% | C12H13ClN4 | 58-14-0 | Details |
| N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanine, ≥ 98.0% | C15H21NO4 | 82717-96-2 | Details |
| Sodium Stearyl Fumarate, ≥ 98.0% | C22H41NaO4 | 4070-80-8 | Details |
| L-Homoarginine Hydrochloride, ≥ 97.0% | C7H17ClN4O2 | 1483-01-8 | Details |
| Methyl Thiocyanate, ≥ 99.0% | C2H3NS | 556-64-9 | Details |
| Salicylanilide, ≥ 98.0% | C13H11NO2 | 87-17-2 | Details |
| Nilvadipine, ≥ 95.0% | C19H19N3O6 | 75530-68-6 | Details |
| N,N-Dimethylsulfamide, ≥ 98.0% | C2H8N2O2S | 3984-14-3 | Details |
| Sorafenib | C21H16ClF3N4O3 | 284461-73-0 | Details |
| Methyl Levulinate, ≥ 99.0% | C6H10O3 | 624-45-3 | Details |
| Methoxycyclopentane, stabilized with BHT, ≥ 98.0% | C6H12O | 5614-37-9 | Details |
| N-Methylformanilide, ≥ 99.0% | C8H9NO | 93-61-8 | Details |
| Phenyl Trifluoroacetate, ≥ 96.0% | C8H5F3O2 | 500-73-2 | Details |
| Methyl 5-(Aminosulfonyl)-2-methoxybenzoate, ≥ 98.0% | C9H11NO5S | 33045-52-2 | Details |
| Nortropine, ≥ 98.0% | C7H13NO | 538-09-0 | Details |
| Rivastigmine L-Tartrate, ≥ 98.0% | C18H28N2O8 | 129101-54-8 | Details |
| Octadecylbenzene, ≥ 95.0% | C24H42 | 4445-07-2 | Details |
| Nicotinic Acid N-Oxide, ≥ 98.0% | C6H5NO3 | 2398-81-4 | Details |
| Product Total： Product Page： | ||||
| 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 | ||||